This report covers the markets for major HIV/AIDS drug therapies, including protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), and non-nucleoside reverse transcriptase inhibitors (NNRTIs). It also examines a range of emerging drugs and therapies. By evaluating challenges and presenting forecasts both by product and product type, this report offers its users a comprehensive guide to the HIV/AIDS drug markets. This report, which monitors industry changes and analyzes competitive strategies, can help your firm develop a winning plan of action. From Frost & Sullivan.
